Skip to main content
Article
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.
Biology of Blood and Marrow Transplantation (2015)
  • Ryan D. Cassaday, Fred Hutchinson Cancer Research Center
  • Barry E. Storer, Fred Hutchinson Cancer Research Center
  • Mohamed L. Sorror, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • Katherine A. Guthrie, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Joseph G. Rajendran, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Mary E. Flowers, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Andrew R. Rezvani, Stanford University
  • Rainer F. Storb, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Publication Date
January 2, 2015
DOI
10.1016/j.bbmt.2014.10.024
Citation Information
Ryan D. Cassaday, Barry E. Storer, Mohamed L. Sorror, Brenda M. Sandmaier, et al.. "Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation." Biology of Blood and Marrow Transplantation Vol. 21 Iss. 2 (2015) p. 281 - 287
Available at: http://works.bepress.com/john-pagel/78/